Angelini Pharma acquires ThermaCare from GlaxoSmithKline

Angelini Pharma acquired the ThermaCare global business rights, excluding North America, from GSK. The deal also includes the dedicated US manufacturing site for ThermaCare in Albany, Georgia.

The acquired asset supports Angelini Pharma reinforcing both its Consumer Healthcare business and consolidating its International presence. Heat therapy is widely known to help ease muscle pain, reduce soreness, and loosen tight muscles.

ThermaCare uses patented technology that produces real heat to help the body rebuild damaged tissue and accelerate healing. This products are formulated for: Lower Back & Hip, Neck, Wrist & Shoulder, Knee & Elbow, Multi-Purpose Muscle, Multi-Purpose Joint and Menstrual.

Along to prescription drugs, Angelini Pharma is recognized for having built a successful Consumer Healthcare business by consistently delivering high-quality solutions to our customers,” said Angelini Pharma CEO Pierluigi Antonelli.I am convinced that the ThermaCare® deal will represent a significant incremental growth engine for our accelerated international expansion.

- Advertisment -


Borussia Dortmund had over EUR 400 million revenues in financial year 2022/2023

In financial year 2022/2023, the lifting of COVID-19 pandemic related restrictions affecting Borussia Dortmund's business model led to an...